Seattle Seahawks begin sale process after Super Bowl win

Seattle Seahawks begin sale process after Super Bowl win


Dareke Young #83 of the Seattle Seahawks celebrates with teammates during the third quarter of the NFC Championship game against the Los Angeles Rams at Lumen Field on Jan. 25, 2026 in Seattle, Washington.

Jane Gershovich | Getty Images

The Seattle Seahawks are officially up for sale.

The NFL team, which defeated the New England Patriots in Super Bowl 60 earlier this month, announced on Wednesday that it has begun a process through which it could sell the franchise. The process, led by investment bank Allen & Company and law firm Latham & Watkins, is expected to continue through the 2026 off-season.

The Seahawks franchise is owned by the estate of Paul Allen, the Microsoft co-founder who helmed the Seahawks from 1997 until his death in 2018. His sister, Jody Allen, became executor of his estate after his death and took over the leadership of the franchise, overseeing the sale of his assets and donations to charity.

“The Estate of Paul G. Allen today announced it has commenced a formal sale process for the Seattle Seahawks NFL franchise, consistent with Allen’s directive to eventually sell his sports holdings and direct all Estate proceeds to philanthropy,” the franchise wrote on social media.

Prior to the Seahawks’ Super Bowl win, the Seattle team was valued at roughly $7 billion, according to CNBC’s official NFL valuations. In that range, the sale has the potential to become one of the biggest in NFL history, after the Washington Commanders sold for roughly $6 billion in 2023.

A sale would be finalized after NFL owners ratify a purchase agreement, according to the Seahawks.



Source

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Business

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments.  In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall […]

Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive
Business

FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned.  In an interview Wednesday in Washington, D.C., Makary said the FDA aims to make […]

Read More
As Walmart and Target head in different directions, all eyes are on their new CEOs
Business

As Walmart and Target head in different directions, all eyes are on their new CEOs

Walmart CEO John Furner, left, and Target CEO Michael Fiddelke. Walmart (L) | Getty Images (R) When Walmart and Target report holiday earnings this quarter, investors may quickly brush off those results. Instead, they will likely focus more on the two big-box retailers’ futures under new CEOs and the outlook for U.S. consumers in 2026. […]

Read More